Amdipharm Mercury Debtco Limited DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

Related Companies

Amdipharm Mercury Company Limited

AMCo is a rapidly growing international pharmaceutical company, committed to bringing its portfolio of niche medicines to patients in more than 100 countries. AMCo is the result of the merger in 2013 of Amdipharm and the Mercury Pharma Group. The combined businesses are highly complementary to each other, with well established product portfolios, and provide a strong platform for future growth through acquisitions in line with...

AMCo is a rapidly growing international pharmaceutical company, committed to bringing its portfolio of niche medicines to patients in more than 100 countries. AMCo is the result of the merger in 2013 of Amdipharm and the Mercury Pharma Group. The combined businesses are highly complementary to each other, with well established product portfolios, and provide a strong platform for future growth through acquisitions in line with its strategy to build a truly global pharmaceutical company. After the merger in early 2013, AMCo acquired global rights to Fucithalmic from LEO Pharma. It then acquired Abcur AB to create a direct presence in the Nordics, to complement its existing direct presence in the UK, Ireland, France and Benelux. Revenues in 2013 grew 12% to £248 million on a proforma basis.